Developing safe and effective contraceptives for men and women
Official title: BIOLOGICAL TESTING FACILITY - ADMINISTRATION, MANAGEMENT, AND DATABASE MAINTENANCE FOR CONTRACEPTION RESEARCH
Funded at Sri International · NIH-11178289 · Data updated 2026-11-12
This study is working on new birth control options for both men and women to make sure they are safe and effective, so people can have more choices when it comes to contraception.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sri International NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project start | September 4, 2020 |
| Project end | September 3, 2025 |
| Funding year | 2024 |
| Award (this year) | $540,341 |
| NIH project number | 75N94020D00003-P00005-759402000001-1 |
| Project ID | NIH-11178289 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals seeking new contraceptive options or those interested in participating in contraceptive development.
✕Less likely to help
Patients who are not interested in contraception or who have already found suitable contraceptive methods may not benefit from this research.
What this research studies
This research focuses on the preclinical development of new contraceptive products aimed at both men and women. The Biological Testing Facility at the National Institute of Child Health and Human Development (NICHD) conducts essential activities to ensure the safety and effectiveness of these contraceptives. Patients may benefit from advancements in contraceptive options that are being rigorously tested and evaluated. The facility maintains a comprehensive database to support the management and administration of these testing activities.
Why it matters
Potential benefit: If successful, this research could lead to the development of new, safe, and effective contraceptive methods for patients.
How similar studies have gone: Previous research in contraceptive development has shown promise, indicating that this approach could lead to significant advancements in the field.
Where this research is happening
-
Sri International
Menlo Park, United States Active
Researchers
- Principal investigator: Parman, Toufan — Sri International
- Study coordinator: Parman, Toufan
Related research
Other NIH-funded projects on the same topics.
-
Mobile health support to boost PrEP and contraception use among young women in Zambia
A mobile health program helps female university students in Zambia learn about and access HIV prevention and contraception.
-
Blocking CFTR in the cervix to prevent conception without hormones
A non-hormonal approach aims to stop sperm from entering the uterus by making cervical mucus too thick for sperm, potentially offering a new contraception option.
-
Long‑lasting antibody vaginal ring for non‑hormonal birth control
Testing a vaginal ring that slowly releases an antibody to trap sperm and prevent pregnancy for people seeking non‑hormonal contraception.
-
A woman-controlled, nonhormonal on-demand contraceptive device
This project is creating a woman-controlled vaginal device that releases a fabric-like polymer which thickens on contact with semen to help prevent pregnancy.
-
Vaginal ring releasing non-hormonal antibody contraception for month-long use
A monthly vaginal ring delivers a non-hormonal antibody-based contraceptive, offering a convenient, user-controlled option for women who want to avoid daily dosing or invasive procedures.
-
On-demand non-hormonal vaginal contraception with a fast-dissolving antibody tablet
A new on-demand vaginal tablet dissolves quickly to release a monoclonal antibody for non-hormonal contraception.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.